Skip to content
10-Q

Quarterly Report

SUCAMPO PHARMACEUTICALS, INC.

0001171843-17-006456

← back to feed
Filed
Nov 1, 2017 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Oct 26, 2017 46.64M sh
Shares Diluted Q3 2017 · Sep 30, 2017 65.08M sh
Shares Diluted Q3 2017 · Sep 30, 2017 45.34M sh
Shares Diluted Q3 2017 · Sep 30, 2016 43.44M sh
Shares Diluted Q3 2017 · Sep 30, 2016 43.33M sh
Capex Q3 2017 · Sep 30, 2017 $403K
Capex Q3 2017 · Sep 30, 2016 $1.22M
Cash And Equivalents Q3 2017 · Sep 30, 2017 $75.04M
Cash And Equivalents Q3 2017 · Dec 31, 2016 $198.31M
Cash And Equivalents Q3 2017 · Sep 30, 2016 $128.47M
Cash And Equivalents Q3 2017 · Dec 31, 2015 $108.28M
Stockholders Equity Q3 2017 · Sep 30, 2017 $39.63M
Stockholders Equity Q3 2017 · Dec 31, 2016 $167.1M
Current Liabilities Q3 2017 · Sep 30, 2017 $37.18M
Current Liabilities Q3 2017 · Dec 31, 2016 $32.35M
Total Liabilities Q3 2017 · Sep 30, 2017 $348.51M
Total Liabilities Q3 2017 · Dec 31, 2016 $353.75M
Current Assets Q3 2017 · Sep 30, 2017 $190.06M
Current Assets Q3 2017 · Dec 31, 2016 $307.23M
Total Assets Q3 2017 · Sep 30, 2017 $388.14M
Total Assets Q3 2017 · Dec 31, 2016 $520.85M
Eps Diluted Q3 2017 · Sep 30, 2017 $0.19
Eps Diluted Q3 2017 · Sep 30, 2017 −$3.67
Eps Diluted Q3 2017 · Sep 30, 2016 $0.19
Eps Diluted Q3 2017 · Sep 30, 2016 $0.07
Eps Basic Q3 2017 · Sep 30, 2017 $0.22
Eps Basic Q3 2017 · Sep 30, 2017 −$3.67
Eps Basic Q3 2017 · Sep 30, 2016 $0.19
Eps Basic Q3 2017 · Sep 30, 2016 $0.08
Sga Expense Q3 2017 · Sep 30, 2017 $9.97M
Sga Expense Q3 2017 · Sep 30, 2017 $39.25M
Sga Expense Q3 2017 · Sep 30, 2016 $11.06M
Sga Expense Q3 2017 · Sep 30, 2016 $32.41M
Rd Expense Q3 2017 · Sep 30, 2017 $10.13M
Rd Expense Q3 2017 · Sep 30, 2017 $39.56M
Rd Expense Q3 2017 · Sep 30, 2016 $9.98M
Rd Expense Q3 2017 · Sep 30, 2016 $35.58M
Net Income Q3 2017 · Sep 30, 2017 $10.37M
Net Income Q3 2017 · Sep 30, 2017 −$166.18M
Net Income Q3 2017 · Sep 30, 2016 $8.09M
Net Income restated Q3 2017 · Sep 30, 2016 $3.2M
Operating Income Q3 2017 · Sep 30, 2017 $21.2M
Operating Income Q3 2017 · Sep 30, 2017 −$143.77M
Operating Income Q3 2017 · Sep 30, 2016 $13.27M
Operating Income Q3 2017 · Sep 30, 2016 $20.38M
Cost Of Revenue Q3 2017 · Sep 30, 2017 $17.44M
Cost Of Revenue Q3 2017 · Sep 30, 2017 $51.35M
Cost Of Revenue Q3 2017 · Sep 30, 2016 $15.59M
Cost Of Revenue Q3 2017 · Sep 30, 2016 $59.28M
Revenue Q3 2017 · Sep 30, 2017 $61.27M
Revenue Q3 2017 · Sep 30, 2017 $177.45M
Revenue Q3 2017 · Sep 30, 2016 $57.87M
Revenue Q3 2017 · Sep 30, 2016 $157.03M